(3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one

C16H25N5O3S — CID 133115824

IUPAC(3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one
SMILESCc1nnsc1CN1C[C@@H]2OC(=O)N(CCCN3CCOCC3)[C@@H]2C1
InChIInChI=1S/C16H25N5O3S/c1-12-15(25-18-17-12)11-20-9-13-14(10-20)24-16(22)21(13)4-2-3-19-5-7-23-8-6-19/h13-14H,2-11H2,1H3/t13-,14+/m1/s1
InChIKeyYIZVZAPCBWXEMB-KGLIPLIRSA-N
MW367.48 g/mol
LogP0.57
Rot. Bonds6

About (3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one

(3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one (PubChem CID 133115824) has the molecular formula C16H25N5O3S and a molecular weight of 367.48 g/mol. Its IUPAC name is (3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one.

Molecular Properties

Compound Name(3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one
PubChem CID133115824
Molecular FormulaC16H25N5O3S
Molecular Weight367.48 g/mol
Exact Mass367.17
IUPAC Name(3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one
SMILESCc1nnsc1CN1C[C@@H]2OC(=O)N(CCCN3CCOCC3)[C@@H]2C1
InChIInChI=1S/C16H25N5O3S/c1-12-15(25-18-17-12)11-20-9-13-14(10-20)24-16(22)21(13)4-2-3-19-5-7-23-8-6-19/h13-14H,2-11H2,1H3/t13-,14+/m1/s1
InChIKeyYIZVZAPCBWXEMB-KGLIPLIRSA-N
XLogP0.57
TPSA71.03 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500367.48
LogP ≤ 50.57
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze (3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one?
The IUPAC name of (3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one (CID 133115824) is (3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one.
What is the SMILES notation for (3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one?
The canonical SMILES for (3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one is Cc1nnsc1CN1C[C@@H]2OC(=O)N(CCCN3CCOCC3)[C@@H]2C1.
What is the InChIKey of (3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one?
The InChIKey is YIZVZAPCBWXEMB-KGLIPLIRSA-N. The full InChI is InChI=1S/C16H25N5O3S/c1-12-15(25-18-17-12)11-20-9-13-14(10-20)24-16(22)21(13)4-2-3-19-5-7-23-8-6-19/h13-14H,2-11H2,1H3/t13-,14+/m1/s1.
What are the key properties of (3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one?
(3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one has a molecular weight of 367.48 g/mol, XLogP of 0.57, 6 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (3aR,6aS)-5-[(4-methylthiadiazol-5-yl)methyl]-3-(3-morpholin-4-ylpropyl)-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,3]oxazol-2-one is sourced from PubChem (CID 133115824), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).